SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,842,415 | -26.4% | 539,665 | +5.3% | 2.28% | -19.8% |
Q2 2023 | $5,220,714 | +12.7% | 512,337 | +0.3% | 2.84% | +25.9% |
Q1 2023 | $4,631,577 | +3.0% | 510,648 | -18.6% | 2.26% | -14.9% |
Q4 2022 | $4,498,121 | +266.0% | 627,353 | +232.8% | 2.66% | +252.6% |
Q3 2022 | $1,229,000 | -31.1% | 188,522 | -43.9% | 0.75% | -28.2% |
Q2 2022 | $1,784,000 | -9.9% | 335,985 | -3.6% | 1.05% | +14.8% |
Q1 2022 | $1,979,000 | +18.5% | 348,425 | +4.7% | 0.91% | +10.5% |
Q4 2021 | $1,670,000 | -16.5% | 332,647 | +10.6% | 0.83% | -8.1% |
Q3 2021 | $2,000,000 | +99.6% | 300,760 | +83.4% | 0.90% | +141.3% |
Q2 2021 | $1,002,000 | -29.6% | 163,994 | -23.4% | 0.37% | -45.9% |
Q1 2021 | $1,423,000 | +65.1% | 214,060 | +31.4% | 0.69% | +1.0% |
Q4 2020 | $862,000 | -34.1% | 162,875 | -7.2% | 0.68% | -36.3% |
Q3 2020 | $1,308,000 | +1.2% | 175,526 | 0.0% | 1.07% | +69.0% |
Q2 2020 | $1,292,000 | +21.5% | 175,526 | +22.2% | 0.64% | -2.9% |
Q1 2020 | $1,063,000 | +51.0% | 143,646 | +15.4% | 0.65% | +89.6% |
Q4 2019 | $704,000 | – | 124,505 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |